Phase II trial of alimta plus gemzar administered every 21 days in patients with advanced pancreatic cancer

✍ Scribed by Kindler, H.; Strickland, D.; Dugan, W.; Visconti, J.; Liebman, J.; Hochster, H.; Jacobs, A.; Kugler, J.; John, W.

• Book ID: 122688401
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 177 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81643-9